Cargando…

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer

Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samtani, Suraj, Burotto, Mauricio, Roman, Juan Carlos, Cortes-Herrera, Daniela, Walton-Diaz, Annerleim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466276/ https://www.ncbi.nlm.nih.gov/pubmed/34573893 http://dx.doi.org/10.3390/diagnostics11091551

Ejemplares similares

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

Adjuvant therapy for renal cell carcinoma, finally a new standard?
por: Renner, Alex, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
por: Renner, Alex, et al.
Publicado: (2019)

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature
por: Salinas, Carlos, et al.
Publicado: (2020)

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors
por: Kareff, Samuel A., et al.
Publicado: (2021)

The Accuracy of Transrectal Ultrasound-Guided Biopsy for Decision Making in Prostate Cancer
por: Ghadian, Ali Reza, et al.
Publicado: (2014)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
por: Mandel, Philipp, et al.
Publicado: (2021)

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020)

Individualized Decision Making in Transperineal Prostate Biopsy: Should All Men Undergo an Additional Systematic Biopsy?
por: Sigle, August, et al.
Publicado: (2022)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Improving workflow in prostate MRI: AI-based decision-making on biparametric or multiparametric MRI
por: Hötker, Andreas M., et al.
Publicado: (2021)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
por: Abd Ali, Furat, et al.
Publicado: (2023)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

How honey bees make fast and accurate decisions
por: MaBouDi, HaDi, et al.
Publicado: (2023)

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
por: Valenzuela, Guillermo, et al.
Publicado: (2022)

Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses
por: Ellmann, Stephan, et al.
Publicado: (2020)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
por: Verbeek, Jan F.M., et al.
Publicado: (2019)

PSA change after antibiotic treatment should not affect decision-making on performing a prostate biopsy
por: KAYALI, Yunus, et al.
Publicado: (2022)

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions
por: Schoots, Ivo G., et al.
Publicado: (2019)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Utilization of MRI in surgical decision making in the shoulder
por: Simon, Maciej J. K., et al.
Publicado: (2022)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Implementing liquid biopsies into clinical decision making for cancer immunotherapy
por: Quandt, Dagmar, et al.
Publicado: (2017)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

Why Can't We Accurately Predict Others' Decisions? Prediction Discrepancy in Risky Decision-Making
por: Sun, Qingzhou, et al.
Publicado: (2018)

Dilemmas Over the Decision to Perform Repeat Prostate Biopsies
por: Hong, Sung Kyu
Publicado: (2014)

The Clinical Value of Performing an MRI before Prostate Biopsy
por: Choi, Myung Sun, et al.
Publicado: (2011)

MRI-targeted prostate biopsy: the next step forward!
por: Cata, Emanuel Darius, et al.
Publicado: (2021)

Critical appraisal skills are essential to informed decision-making
por: Mhaskar, Rahul, et al.
Publicado: (2009)

Heart and Mind: Essential Components in Sound Decision-Making
por: Clark, Michaela, et al.
Publicado: (2020)

Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer
por: Burotto, Mauricio, et al.
Publicado: (2014)

The presence of LUTS is not a decisive tool for deciding who should be qualified for prostate biopsy
por: Juszczak, Kajetan
Publicado: (2014)

Predicting side-specific prostate cancer extracapsular extension: a simple decision rule of PSA, biopsy, and MRI parameters
por: Zapała, Piotr, et al.
Publicado: (2019)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
por: Jahnen, Matthias, et al.
Publicado: (2023)

The impact of MRI scanner environment on perceptual decision-making
por: van Maanen, Leendert, et al.
Publicado: (2015)

A personalized decision aid for prostate cancer shared decision making
por: Bagshaw, Hilary P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bvipp033hjcg9imp1318h7lrgj